Global Cannabinoid Solutions is Britain's cannabinoid research hub.

An entire industry has been built on a biological system most of it has never measured. Our mission is to close the distance between what this market claims and what the science can actually support — because that distance is where commercial risk sits, where clinical confidence erodes, and where the sector's credibility is won or lost.

We work across the endocannabinoid system: receptor pharmacology, formulation, toxicology, regulatory science and clinical practice. Our work exists so that decisions taken in this field can be defended — to a regulator, to an investment committee, to a patient.

Our events bring that work into the open. We host scientific webinars, clinical education sessions and industry briefings, led by the people doing the research and built for the people who carry the decisions: clinical leads, founders, boards and investors. Every session leaves room for the questions that matter.

Founded 2019. Based in North Yorkshire.